{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:50:42Z","timestamp":1792183842248,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11910-013-0387-7","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T07:53:56Z","timestamp":1376639636000},"source":"Crossref","is-referenced-by-count":47,"title":["Update on HIV-Associated Neurocognitive Disorders"],"prefix":"10.1007","volume":"13","author":[{"given":"Tariq B.","family":"Alfahad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,17]]},"reference":[{"key":"387_CR1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bmj.332.7553.1289","volume":"332","author":"JH Tanne","year":"2006","unstructured":"Tanne JH. Nearly 40 million people worldwide are infected with HIV. BMJ. 2006;332:1289.","journal-title":"BMJ"},{"issue":"6","key":"387_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7861\/clinmedicine.11-6-571","volume":"11","author":"C Hogan","year":"2011","unstructured":"Hogan C, Wilkins E. Neurological complications in HIV. Clin Med. 2011;11(6):571\u20135.","journal-title":"Clin Med"},{"key":"387_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"\u2022\u2022 Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3\u201316. This study shows in a large multicenter cohort that the prevalence of HAND is still substantial despite adequate ART.","journal-title":"J Neurovirol"},{"issue":"4","key":"387_CR4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13803390590949494","volume":"28","author":"CL Carey","year":"2006","unstructured":"Carey CL, Woods SP, Rippeth JD, et al. Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol. 2006;28(4):536\u201348.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"12","key":"387_CR5","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"CH Hinkin","year":"2002","unstructured":"Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944\u201350.","journal-title":"Neurology"},{"key":"387_CR6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000034175.11956.79","volume":"59","author":"M Cherner","year":"2002","unstructured":"Cherner M, Masliah E, Ellis RJ, et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002;59:1563\u20137.","journal-title":"Neurology"},{"issue":"18","key":"387_CR7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789\u201399.","journal-title":"Neurology"},{"issue":"1","key":"387_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","volume":"8","author":"R Ellis","year":"2007","unstructured":"Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci. 2007;8(1):33\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"387_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","volume":"4","author":"JC McArthur","year":"2005","unstructured":"McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4(9):543\u201355.","journal-title":"Lancet Neurol"},{"issue":"1","key":"387_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3\u201316.","journal-title":"J Neurovirol"},{"issue":"3","key":"387_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WCO.0b013e328346be57","volume":"24","author":"T Johnson","year":"2011","unstructured":"\u2022 Johnson T, Nath A. Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol. 2011;24(3):284\u201390. This review discusses the clinical manifestations, pathophysiology, and management of IRIS affecting the CNS in HIV-infected individuals.","journal-title":"Curr Opin Neurol"},{"key":"387_CR12","doi-asserted-by":"crossref","first-page":"13795","DOI":"10.1073\/pnas.202357499","volume":"99","author":"E Gonzalez","year":"2002","unstructured":"Gonzalez E, Rovin BH, Sen L, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A. 2002;99:13795.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"387_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jneuroim.2004.08.029","volume":"157","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol. 2004;157:197\u2013202.","journal-title":"J Neuroimmunol"},{"key":"387_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2004.08.027","volume":"157","author":"KK Singh","year":"2004","unstructured":"Singh KK, Ellis RJ, Marquie-Beck J, et al. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol. 2004;157:185\u201392.","journal-title":"J Neuroimmunol"},{"key":"387_CR15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014\u201328.","journal-title":"Lancet"},{"key":"387_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1212\/WNL.0b013e3182478d64","volume":"78","author":"JA McCutchan","year":"2012","unstructured":"McCutchan JA, Marquie-Beck JA, Fitzsimons CA, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012;78:485\u201392.","journal-title":"Neurology"},{"key":"387_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.qai.0000243119.67529.f5","volume":"43","author":"VG Valcour","year":"2006","unstructured":"Valcour VG, Sacktor NC, Paul RH, et al. Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging with HIV Cohort. J Acquir Immune Defic Syndr. 2006;43:405\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"387_CR18","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","volume":"43","author":"JC McArthur","year":"1993","unstructured":"McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology. 1993;43:2245\u201352.","journal-title":"Neurology"},{"key":"387_CR19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.0b013e3181bd10e7","volume":"73","author":"JT Becker","year":"2009","unstructured":"Becker JT, Kingsley L, Mullen J, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology. 2009;73:1292\u20139.","journal-title":"Neurology"},{"key":"387_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry. 1998;65:29\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"387_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel HC, Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS. 2005;19:127\u201335.","journal-title":"AIDS"},{"key":"387_CR22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"\u2022 Achim CL, Adame A, Dumaop W, et al. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol. 2009;4:190\u20139. This demonstrates that the amyloid based pathology in HIV infected individuals is distinctly different from that in Alzheimer\u2019s disease.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"Suppl 1","key":"387_CR23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00002030-200401001-00005","volume":"18","author":"M Cherner","year":"2004","unstructured":"Cherner M, Ellis RJ, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004;18 Suppl 1:S27\u201334.","journal-title":"AIDS"},{"key":"387_CR24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","volume":"63","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology. 2004;63:822\u20137.","journal-title":"Neurology"},{"key":"387_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13550280701258423","volume":"13","author":"N Sacktor","year":"2007","unstructured":"Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007;13:203\u20139.","journal-title":"J Neurovirol"},{"key":"387_CR26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/01.aids.0000238404.16121.47","volume":"20","author":"TD Parsons","year":"2006","unstructured":"Parsons TD, Tucker KA, Hall CD, et al. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS. 2006;20:1591\u20135.","journal-title":"AIDS"},{"key":"387_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13550280590952790","volume":"11","author":"V Tozzi","year":"2005","unstructured":"Tozzi V, Balestra P, Lorenzini P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 2005;11:265\u201373.","journal-title":"J Neurovirol"},{"key":"387_CR28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0b013e31827b61f1","volume":"62","author":"B Sun","year":"2013","unstructured":"Sun B, Abadjian L, Rempel H, et al. Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. J Acquir Immune Defic Syndr. 2013;62:190\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"387_CR29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/QAD.0b013e3283437d2f","volume":"25","author":"A Nath","year":"2011","unstructured":"\u2022\u2022 Nath A, Clements JE. Eradication of HIV from the brain: reasons for pause. AIDS. 2011;25(5):577\u201380. This article discusses the challenges in the eradication of HIV from the brain.","journal-title":"AIDS"},{"key":"387_CR30","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","volume":"105","author":"S Palmer","year":"2008","unstructured":"Palmer S, Maldarelli F, Wiegand A, et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A. 2008;105:3879\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"387_CR31","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","volume":"3","author":"F Maldarelli","year":"2007","unstructured":"Maldarelli F, Palmer S, King MS, et al. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog. 2007;3:e46.","journal-title":"PLoS Pathog"},{"issue":"Suppl 2","key":"387_CR32","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/344528","volume":"186","author":"A Nath","year":"2002","unstructured":"Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. 2002;186 Suppl 2:S193\u20138.","journal-title":"J Infect Dis"},{"key":"387_CR33","author":"TP Johnson","year":"2013","unstructured":"Johnson TP, Patel K, Johnson KR, et al. Induction of IL-17 and non-classical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci USA. 2013. doi: 10.1073\/pnas.1308673110 .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"387_CR34","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.23-23-08417.2003","volume":"23","author":"AJ Bruce-Keller","year":"2003","unstructured":"Bruce-Keller AJ, Chauhan A, Dimayuga FO, et al. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci. 2003;23(23):8417\u201322.","journal-title":"J Neurosci"},{"issue":"8","key":"387_CR35","doi-asserted-by":"crossref","first-page":"e43950","DOI":"10.1371\/journal.pone.0043950","volume":"7","author":"T Wang","year":"2012","unstructured":"Wang T, Lee MH, Choi E, et al. Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1. 3 channel. PLoS One. 2012;7(8):e43950.","journal-title":"PLoS One"},{"issue":"8","key":"387_CR36","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1096\/fj.05-5022fje","volume":"20","author":"T Wang","year":"2006","unstructured":"Wang T, Allie R, Conant K, et al. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J. 2006;20(8):1209\u201311.","journal-title":"FASEB J"},{"issue":"6","key":"387_CR37","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008;3(6):e2516.","journal-title":"PLoS One"},{"issue":"11","key":"387_CR38","doi-asserted-by":"crossref","first-page":"e15533","DOI":"10.1371\/journal.pone.0015533","volume":"5","author":"A Kamat","year":"2010","unstructured":"Kamat A, Ancuta P, Blumberg RS, et al. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One. 2010;5(11):e15533.","journal-title":"PLoS One"},{"issue":"1","key":"387_CR39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1742-2094-8-167","volume":"8","author":"S Dohgu","year":"2011","unstructured":"Dohgu S, Fleegal-DeMotta MA, Banks WA. Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF. J Neuroinflammation. 2011;8(1):167.","journal-title":"J Neuroinflammation"},{"issue":"6253","key":"387_CR40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/343085a0","volume":"343","author":"S Pang","year":"1990","unstructured":"Pang S, Koyanagi Y, Miles S, et al. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature. 1990;343(6253):85\u20139.","journal-title":"Nature"},{"issue":"5534","key":"387_CR41","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1061548","volume":"293","author":"Y Wu","year":"2001","unstructured":"Wu Y, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science. 2001;293(5534):1503\u20136.","journal-title":"Science"},{"issue":"4","key":"387_CR42","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/JVI.71.4.2928-2933.1997","volume":"71","author":"I Teo","year":"1997","unstructured":"Teo I, Veryard C, Barnes H, et al. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol. 1997;71(4):2928\u201333.","journal-title":"J Virol"},{"issue":"11","key":"387_CR43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra CM, Zhao Y, Clifford DB, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009;23(11):1359\u201366.","journal-title":"AIDS"},{"issue":"1","key":"387_CR44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s13365-010-0001-6","volume":"17","author":"LR Gray","year":"2011","unstructured":"Gray LR, Gabuzda D, Cowley D, et al. CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates. J Neurovirol. 2011;17(1):82\u201391.","journal-title":"J Neurovirol"},{"issue":"41","key":"387_CR45","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.0605513103","volume":"103","author":"RL Dunfee","year":"2006","unstructured":"Dunfee RL, Thomas ER, Gorry PR, et al. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A. 2006;103(41):15160\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"387_CR46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1742-4690-9-20","volume":"9","author":"MP Gonzalez-Perez","year":"2012","unstructured":"Gonzalez-Perez MP, O'Connell O, Lin R, et al. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology. 2012;9:20.","journal-title":"Retrovirology"},{"issue":"1","key":"387_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13365-010-0002-5","volume":"17","author":"D Cowley","year":"2011","unstructured":"Cowley D, Gray LR, Wesselingh SL, et al. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia. J Neurovirol. 2011;17(1):70\u201381.","journal-title":"J Neurovirol"},{"issue":"47","key":"387_CR48","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.1523\/JNEUROSCI.3019-08.2008","volume":"28","author":"W Li","year":"2008","unstructured":"Li W, Huang Y, Reid R, et al. NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci. 2008;28(47):12190\u20138.","journal-title":"J Neurosci"},{"issue":"4","key":"387_CR49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/aid.2009.0257","volume":"26","author":"KC Olivieri","year":"2010","unstructured":"Olivieri KC, Agopian KA, Mukerji J, et al. Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retrovir. 2010;26(4):495\u2013500.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"387_CR50","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.20304","volume":"56","author":"KA Thompson","year":"2004","unstructured":"Thompson KA, Churchill MJ, Gorry PR, et al. Astrocyte specific viral strains in HIV dementia. Ann Neurol. 2004;56(6):873\u20137.","journal-title":"Ann Neurol"},{"issue":"1","key":"387_CR51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.meegid.2010.10.016","volume":"11","author":"SL Lamers","year":"2011","unstructured":"Lamers SL, Gray RR, Salemi M, et al. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol. 2011;11(1):31\u20137.","journal-title":"Infect Genet Evol"},{"issue":"4","key":"387_CR52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcv.2010.08.001","volume":"49","author":"M Vissers","year":"2010","unstructured":"Vissers M, Stelma FF, Koopmans PP. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? J Clin Virol. 2010;49(4):231\u20138.","journal-title":"J Clin Virol"},{"issue":"3","key":"387_CR53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/13550281003735709","volume":"16","author":"SL Lamers","year":"2010","unstructured":"Lamers SL, Salemi M, Galligan DC, et al. Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol. 2010;16(3):230\u201341.","journal-title":"J Neurovirol"},{"issue":"2","key":"387_CR54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-3542(02)00052-9","volume":"55","author":"S Aquaro","year":"2002","unstructured":"Aquaro S, Calio R, Balzarini J, et al. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res. 2002;55(2):209\u201325.","journal-title":"Antiviral Res"},{"issue":"5","key":"387_CR55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/088922201750102409","volume":"17","author":"P Cinque","year":"2001","unstructured":"Cinque P, Presi S, Bestetti A, et al. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Res Hum Retrovir. 2001;17(5):377\u201383.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"387_CR56","first-page":"45","volume":"18","author":"SL Letendre","year":"2010","unstructured":"Letendre SL, Ellis RJ, Ances BM, McCutchan JA. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010;18(2):45\u201355.","journal-title":"Top HIV Med"},{"issue":"6031","key":"387_CR57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.332.6031.786","volume":"332","author":"J Cohen","year":"2011","unstructured":"\u2022 Cohen J. Understanding HIV latency to undo it. Science. 2011;332(6031):786. This reviews all the ongoing clinical trials for eradication of HIV infection.","journal-title":"Science"},{"issue":"3","key":"387_CR58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WCO.0b013e328346be57","volume":"24","author":"T Johnson","year":"2011","unstructured":"Johnson T, Nath A. Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol. 2011;24(3):284\u201390.","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"387_CR59","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","volume":"28","author":"N Holt","year":"2010","unstructured":"Holt N, Wang J, Kim K, et al. Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol. 2010;28(8):839\u201347.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"387_CR60","first-page":"432","volume":"4","author":"L Ene","year":"2011","unstructured":"Ene L, Duiculescu D, Ruta SM. How much do antiretroviral drugs penetrate into the central nervous system? J Med Life. 2011;4(4):432.","journal-title":"J Med Life"},{"issue":"1","key":"387_CR61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(99)00017-4","volume":"39","author":"RJ Sawchuk","year":"1999","unstructured":"Sawchuk RJ, Yang Z. Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system. Adv Drug Deliv Rev. 1999;39(1):5\u201331.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"387_CR62","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/AAC.00507-10","volume":"54","author":"D Croteau","year":"2010","unstructured":"Croteau D, Letendre S, Best BM, et al. Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010;54(12):5156\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"387_CR63","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/infdis\/jir667","volume":"204","author":"V Dahl","year":"2011","unstructured":"Dahl V, Lee E, Peterson J, et al. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis. 2011;204(12):1936\u201345.","journal-title":"J Infect Dis"},{"issue":"5","key":"387_CR64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/nnm.09.38","volume":"4","author":"A Nowacek","year":"2009","unstructured":"Nowacek A, Gendelman HE. NanoART, neuroAIDS and CNS drug delivery. Nanomedicine. 2009;4(5):557\u201374.","journal-title":"Nanomedicine"},{"issue":"33","key":"387_CR65","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","volume":"29","author":"KS Rao","year":"2008","unstructured":"Rao KS, Reddy MK, Horning JL. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 2008;29(33):4429\u201338.","journal-title":"Biomaterials"},{"issue":"2","key":"387_CR66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/11597770-000000000-00000","volume":"26","author":"IL Tan","year":"2012","unstructured":"Tan IL, McArthur JC. HIV-Associated neurological disorders. CNS Drugs. 2012;26(2):123\u201334.","journal-title":"CNS Drugs"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-013-0387-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0387-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T02:29:59Z","timestamp":1596335399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-013-0387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,17]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s11910-013-0387-7","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,17]]},"article-number":"387"}}